Aims: To compare glycaemic control and risk of hypoglycaemia of twice-daily insulin detemir with once-daily insulin glargine in subjects with Type 1 diabetes.

• 目的：比较1型糖尿病患者每日2次地特胰岛素与每日1次甘精胰岛素治疗的血糖控制水平和低血糖风险。